Table 5 Clinical events in the cohort of NVAF patients treated with Apixaban and warfarin
VKA Suitable patients | ||
|---|---|---|
Number of events (Total population)ischemic strock | Apixaban | Warfarin |
Non-fatal Mild | 80 | 80 |
Non-fatal Moderate | 68 | 73 |
Non-fatal Severe | 27 | 28 |
Fatal | 25 | 25 |
TOTAL | 200 | 206 |
Recurrent Islamic Stroke | ||
Non-fatal Mild | 4 | 4 |
Non-fatal Moderate | 6 | 7 |
Non-fatal Severe | 5 | 6 |
Fatal | 4 | 4 |
TOTAL | 20 | 21 |
Hemorrhagic Stroke | ||
Non-fatal Mild | 4 | 7 |
Non-fatal Moderate | 6 | 6 |
Non-fatal Severe | 4 | 6 |
Fatal | 9 | 21 |
TOTAL | 23 | 40 |
Recurrent Hemorrhagic Stroke | ||
Non-fatal Mild | 0 | 0 |
Non-fatal Moderate | 0 | 0 |
Non-fatal Severe | 0 | 1 |
Fatal | 0 | 0 |
TOTAL | 1 | 2 |
Systematic Embolism | ||
Non fatal | 19 | 19 |
Fatal | 2 | 2 |
TOTAL | 22 | 21 |
Other ICH | ||
Non fatal | 9 | 21 |
Fatal | 1 | 3 |
TOTAL | 11 | 24 |
Other Major Bleeds | ||
Non-fatal GI Bleeds | 54 | 55 |
Non-fatal Non ICH or Non GI Related Major Bleeds Fatal | 88 | 98 |
Fatal | 3 | 3 |
TOTAL | 145 | 155 |
Clinically Relevant Non-Major Bleeds | 252 | 287 |
MI | ||
Non fatal | 67 | 67 |
Fatal | 8 | 8 |
TOTAL | 75 | 75 |
Other CV Hospitalization | 1.060 | 1.020 |
Other Treatment Discontinuation | 579 | 591 |
Deaths | ||
Event Related (acute) | 51 | 65 |
Event related (death due to stroke, HS,MI, SE) | 273 | 285 |
Other | 676 | 650 |
TOTAL | 1.000 | 1.000 |